Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma
Authors:
- Kyoichi KairaKKKyoichi Kaira
- Noboru OriuchiNONoboru Oriuchi
- Hisao ImaiHIHisao Imai
- Kimihiro ShimizuKSKimihiro Shimizu
- Noriko YanagitaniNYNoriko Yanagitani
- Noriaki SunagaNSNoriaki Sunaga
- Takeshi HisadaTHTakeshi Hisada
- Tamotsu IshizukaTITamotsu Ishizuka
- Yoshikatsu KanaiYKYoshikatsu Kanai
- Takashi NakajimaTNTakashi Nakajima
- Masatomo MoriMMMasatomo Mori
- 1 October 2009
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 66 (1) , 120-126
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancerBritish Journal of Cancer, 2008
- Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tractVirchows Archiv, 2007
- L‐type amino acid transporter 1 as a potential molecular target in human astrocytic tumorsInternational Journal of Cancer, 2006
- Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?Seminars in Cancer Biology, 2005
- Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)Journal of Biological Chemistry, 1998
- Revisions in the International System for Staging Lung CancerChest, 1997
- Regulatory and molecular aspects of mammalian amino acid transportBiochemical Journal, 1994
- Role of amino acid transport and countertransport in nutrition and metabolism.Physiological Reviews, 1990
- Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 CM in diameterCancer, 1988
- Evidence for two Types of Mediation of Neutral Amino-Acid Transport in Ehrlich CellsNature, 1963